Integrated BioPharma (INBP) Insider Desantis Buys 50,000 Shares
Damon Desantis acquired 50,000 shares of INBP on June 24, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Damon Desantis bought 50,000 shares of Integrated BioPharma, Inc. ($INBP) on June 24, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $INBP is up 0.0% after 1 week, down 11.1% after 1 month and up 0.0% to date (from the $0.18 close on Jun 24, 2026).
INBP
Integrated BioPharma, Inc.
Key Points
- Damon Desantis purchased 50,000 shares of INBP on June 24, 2026, with shares trading around $0.18.
- The transaction was not part of a pre-planned trading program and involved multiple insiders buying the same amount.
- INBP's stock traded near $0.18 on Thursday, reflecting recent insider buying activity.
Get $INBP trade alerts by text
We text you when insiders, Congress or big funds trade $INBP. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Integrated BioPharma, Inc. alert may contain errors. Disclosures
Damon Desantis recently purchased 50,000 shares of INBP on June 24, 2026. This insider buying activity was not part of a pre-planned trading program and adds to the interest in the company's stock, which traded near $0.18 on Thursday.
Insider Buying and Selling at Integrated BioPharma, Inc.
On June 24, 2026, several insiders, including Damon Desantis, bought 50,000 shares each of INBP. Other insiders such as Eric Friedman and Robert Canarick made similar purchases on the same day. These transactions were not under Rule 10b5-1 plans, indicating they were not pre-scheduled. Additionally, William Milmoe sold 11,201,964 shares on April 15, 2026, in a separate transaction.
Bottom Line
The recent insider buying at INBP, particularly by Damon Desantis and other key figures, highlights notable interest in the company's stock. Investors often track such transactions to gauge insider confidence. This buying activity offers a glimpse into the internal sentiment at INBP, although it should be noted these transactions are not predictive of future stock performance.
Related Filing Alerts
Source: Damon Desantis's Form 4 filing on $INBP (Jun 24, 2026). Find the original filing: INBP Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts